Immunome (IMNM) Price Forecast Summary
Published: April 14, 2026
Key Points
- Bull pennant breakout signals continuation of recovery.
- Higher low at $19.16 defines correction bottom.
- Strong demand confirmed by volume spike.
- $22.81 remains key confirmation resistance level.
- Upside targets align with rising channel structure.
Recovery Structure Takes Shape After Correction
Shares of Immunome Inc. (IMNM) are showing signs of strength following a significant 30.7% decline from the February trend high of $27.65. A higher swing low was established at $19.16 in late March, marking the bottom of the bearish correction. Recently, IMNM broke out of a short 10-day price range that formed a bull pennant pattern, indicating a potential continuation of the recovery.
Confluence Support Reinforces Bullish Structure
The bullish pennant pattern indicates strong demand during the consolidation period, forming within a support zone at the convergence of key moving averages (10-day, 20-day, and 100-day). The low of the short pullback completed a 61.8% Fibonacci retracement of the prior advance. The 50-day moving average was reclaimed, with the session closing at its highest daily closing price since the March bottom, supported by a significant volume spike.
Reversal Signal Builds, Confirmation Still Pending
A bullish trend reversal signal was generated during the 20.8% rally from the $19.16 low. Although the lower swing high at $22.81 was briefly exceeded, the trend reversal signal did not confirm with a daily close above it. This highlights the potential of the developing rally once the correction completes.
Breakout Aligns With Rising Channel Structure
On Tuesday, a decisive breakout of the pennant was triggered, leading to a new high of $23.68 for the near-term advance. This breakout aligns with the middle line of a large ascending trend channel, suggesting that the long-term bull trend is ready to resume. A daily close above the $22.81 high is needed to confirm sustained demand and reinforce the broader bullish structure.
Outlook: Path Toward Prior Highs
The analysis suggests that there is clear potential for Immunome to eventually reach new highs, possibly above the $27.65 trend high. The next critical step is achieving a daily close above the $22.81 high to confirm the bullish outlook.
About the Author
Bruce Powers is a seasoned finance MBA and CMT® charter holder with over 20 years of experience in financial markets. He has worked as head of trading strategy at hedge funds and as a corporate advisor for trading firms, providing actionable insights through both technical and fundamental analyses.